| Literature DB >> 25542480 |
Monica Luongo1, Rosina Critelli1, Antonella Grottola2, Stefano Gitto1, Veronica Bernabucci1, Mirco Bevini3, Chiara Vecchi3, Giuliano Montagnani3, Erica Villa4.
Abstract
HBV vaccine contains the 'a' determinant region, the major immune-target of antibodies (anti-HBs). Failure of immunization may be caused by vaccine-induced or spontaneous 'a' determinant surface gene mutants. Here, we evaluate the possible lack of protection by HBV vaccine, describing the case of an acute hepatitis B diagnosed in a 55-year-old Caucasian male unpaid blood donor, vaccinated against HBV. Sequencing data for preS-S region revealed multiple point mutations. Of all the substitutions found, Q129H, located in the "a" determinant region of HBsAg, can alter antigenicity, leading to mutants. This mutant may cause vaccine failure especially when associated with high viremia of infecting source.Entities:
Keywords: Acute hepatitis; Escape mutant; Hepatitis B virus; Telbivudine; Vaccine
Mesh:
Substances:
Year: 2014 PMID: 25542480 DOI: 10.1016/j.jcv.2014.11.029
Source DB: PubMed Journal: J Clin Virol ISSN: 1386-6532 Impact factor: 3.168